TY - JOUR
T1 - Preformulation studies on Imexon
AU - Kuehl, P. J.
AU - Hoye, W. L.
AU - Myrdal, P. B.
N1 - Funding Information:
authors would also like to graciously thank Amplimed Corporation for their financial support throughout this project.
Funding Information:
Mass Spectra were acquired in the AZCC/SWE-HSC Proteomics Core supported by NIEHS grant ES06694 and NIH/NCI grant CA023074–26. The
PY - 2006/6/1
Y1 - 2006/6/1
N2 - Imexon is an aziridine containing iminopyrrolidone that, through aziridine ring opening, is able to induce oxidative stress resulting in apoptosis. The main objective of this research was to conduct extensive preformulation studies on Imexon in order to understand the factors that affect its stability. The results obtained indicate that the stability of Imexon is dependant on pH, ionic strength, temperature, buffer species, and initial concentration. Degradation of Imexon follows apparent first-order degradation kinetics with the primary degradation product resulting from opening of the aziridine ring. In order to maximize stability, ionic strength, temperature, and initial concentration should be minimized, with an optimal range pH between 7.2 and 9.0. Experimentation with other aqueous solutions indicates that Imexon has increased stability in D5W as opposed to normal saline, while it undergoes rapid degradation in 6% H 2 O 2 . Imexon is not ionizable between pH 5.0 to 8.5 and has an aqueous solubility of approximately 25 mg/mL over this range. Solid-state characterization has concluded that Imexon is a crystalline solid that begins decomposition at 165°C, prior to melting.
AB - Imexon is an aziridine containing iminopyrrolidone that, through aziridine ring opening, is able to induce oxidative stress resulting in apoptosis. The main objective of this research was to conduct extensive preformulation studies on Imexon in order to understand the factors that affect its stability. The results obtained indicate that the stability of Imexon is dependant on pH, ionic strength, temperature, buffer species, and initial concentration. Degradation of Imexon follows apparent first-order degradation kinetics with the primary degradation product resulting from opening of the aziridine ring. In order to maximize stability, ionic strength, temperature, and initial concentration should be minimized, with an optimal range pH between 7.2 and 9.0. Experimentation with other aqueous solutions indicates that Imexon has increased stability in D5W as opposed to normal saline, while it undergoes rapid degradation in 6% H 2 O 2 . Imexon is not ionizable between pH 5.0 to 8.5 and has an aqueous solubility of approximately 25 mg/mL over this range. Solid-state characterization has concluded that Imexon is a crystalline solid that begins decomposition at 165°C, prior to melting.
KW - General acid/base catalysis
KW - Imexon
KW - Preformulation studies
KW - Solubility
KW - pH stability
UR - http://www.scopus.com/inward/record.url?scp=33746845625&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33746845625&partnerID=8YFLogxK
U2 - 10.1080/03639040600599830
DO - 10.1080/03639040600599830
M3 - Article
C2 - 16885124
AN - SCOPUS:33746845625
SN - 0363-9045
VL - 32
SP - 687
EP - 697
JO - Drug Development and Industrial Pharmacy
JF - Drug Development and Industrial Pharmacy
IS - 6
ER -